In this sense, LAB-based mucosal vaccines are an attractive option for the prevention and treatment of allergic diseases.133–136 A mucosal vaccine based on L. lactis expressing major dust mite allergen Der p2 was developed, and its prophylactic effect was evaluated in a Der p2-sensitized mouse model. The gene discussed is GHITM; the disease is allergic disease.